|
DE3537761A1
(de)
|
1985-10-24 |
1987-04-30 |
Bayer Ag |
Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
|
|
JPH0276860A
(ja)
|
1987-10-05 |
1990-03-16 |
Toyo Jozo Co Ltd |
６−置換アルコキシ−２−オキソ−１，２−ジヒドロキノキサリン誘導体
|
|
FR2645152B1
(fr)
|
1989-03-30 |
1991-05-31 |
Lipha |
3h-pteridinones-4, procedes de preparation et medicaments les contenant
|
|
US5043270A
(en)
|
1989-03-31 |
1991-08-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Intronic overexpression vectors
|
|
US5198547A
(en)
|
1992-03-16 |
1993-03-30 |
South Alabama Medical Science Foundation, Usa |
Process for N5-formylating tetrahydropteridines
|
|
TW274550B
(https=)
|
1992-09-26 |
1996-04-21 |
Hoechst Ag |
|
|
EP1195372A1
(en)
|
1994-04-18 |
2002-04-10 |
Mitsubishi Pharma Corporation |
N-heterocyclic substituted benzamide derivatives with antihypertensive activity
|
|
GB9418499D0
(en)
|
1994-09-14 |
1994-11-02 |
Ciba Geigy Ag |
Process for producing n-methylated organic pigments
|
|
CO4410190A1
(es)
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
|
|
IL117923A
(en)
|
1995-05-03 |
2000-06-01 |
Warner Lambert Co |
Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
|
|
AU5814596A
(en)
|
1995-05-19 |
1996-11-29 |
Novartis Ag |
Process for the catalytic hydrogenation of aromatic nitro compounds
|
|
US5698556A
(en)
|
1995-06-07 |
1997-12-16 |
Chan; Carcy L. |
Methotrexate analogs and methods of using same
|
|
JP2001500878A
(ja)
|
1996-09-23 |
2001-01-23 |
イーライ・リリー・アンド・カンパニー |
オランザピン二水和物ｄ
|
|
ID27843A
(id)
|
1998-08-11 |
2001-04-26 |
Pfizer Prod Inc |
Substitusi 1, 8-naftiridin-4(ih)-on sebagai penghambat fosfodiesterase 4
|
|
US7169778B2
(en)
|
1999-09-15 |
2007-01-30 |
Warner-Lambert Company |
Pteridinones as kinase inhibitors
|
|
GB2359551A
(en)
|
2000-02-23 |
2001-08-29 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
|
AP2002002643A0
(en)
|
2000-03-06 |
2002-12-31 |
Warner Lambert Co |
5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
|
|
DE10018783A1
(de)
|
2000-04-15 |
2001-10-25 |
Fresenius Kabi De Gmbh |
Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
|
|
US20020183292A1
(en)
|
2000-10-31 |
2002-12-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
|
DE10058119A1
(de)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
Pepinotan-Kit
|
|
US6756374B2
(en)
|
2001-01-22 |
2004-06-29 |
Hoffmann-La Roche Inc. |
Diaminothiazoles having antiproliferative activity
|
|
US6960589B2
(en)
|
2001-03-09 |
2005-11-01 |
Abbott Laboratories |
Benzimidazoles that are useful in treating sexual dysfunction
|
|
WO2002076985A1
(en)
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
WO2002076954A1
(en)
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
JP4825375B2
(ja)
|
2001-08-28 |
2011-11-30 |
株式会社 資生堂 |
ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤
|
|
UA76512C2
(en)
|
2001-09-04 |
2006-08-15 |
Boehringer Ingelheim Pharma |
Dihydropteridinones, a method for producing thereof and use thereof as medicament
|
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US7507707B2
(en)
|
2001-12-14 |
2009-03-24 |
Laboratoires Serono Sa |
Methods of inducing ovulation using a non-polypeptide camp level modulator
|
|
US20060079503A1
(en)
|
2002-05-03 |
2006-04-13 |
Schering Aktiengesellschaft |
Thiazolidinones and the use therof as polo-like kinase inhibitors
|
|
FR2843114B1
(fr)
|
2002-08-01 |
2004-09-10 |
Poudres & Explosifs Ste Nale |
Procede de monomethylation d'heterocycles azotes
|
|
BR0313160A
(pt)
|
2002-08-08 |
2005-07-12 |
Smithkline Beecham Corp |
Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
|
|
US20040127504A1
(en)
|
2002-09-06 |
2004-07-01 |
Cowart Marlon D. |
Benzimidazoles that are useful in treating sexual dysfunction
|
|
GB2398565A
(en)
|
2003-02-18 |
2004-08-25 |
Cipla Ltd |
Imatinib preparation and salts
|
|
JP3876265B2
(ja)
|
2003-02-26 |
2007-01-31 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
ジヒドロプテリジノン、その製造方法及び薬物形態での使用
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
CN1764474B
(zh)
|
2003-03-26 |
2011-02-02 |
惠氏公司 |
免疫原性组合物及方法
|
|
JP2006522634A
(ja)
|
2003-04-14 |
2006-10-05 |
ベクトゥラ・リミテッド |
投与効率を向上させるデバイス及び製薬組成
|
|
DE102004002557A1
(de)
|
2004-01-17 |
2005-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
|
|
CA2552540A1
(en)
|
2004-01-17 |
2005-07-28 |
Boehringer Ingelheim International Gmbh |
Use of substituted pteridines for the treatment of diseases of the respiratory tract
|
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE102004033670A1
(de)
|
2004-07-09 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
|
|
DE102004034623A1
(de)
|
2004-07-16 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US7728134B2
(en)
|
2004-08-14 |
2010-06-01 |
Boehringer Ingelheim International Gmbh |
Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
EP1630163A1
(de)
|
2004-08-25 |
2006-03-01 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1632493A1
(de)
|
2004-08-25 |
2006-03-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1786817A1
(de)
|
2004-08-26 |
2007-05-23 |
Boehringer Ingelheim International GmbH |
Pteridinone als plk (polo like kinase) inhibitoren
|
|
WO2006021548A1
(de)
|
2004-08-27 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
|
DE102004058337A1
(de)
|
2004-12-02 |
2006-06-14 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
|
|
CA2617589A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
|
PT1948180E
(pt)
|
2005-11-11 |
2013-05-10 |
Boehringer Ingelheim Int |
Tratamento de combinação de cancro compreendendo inibidores de egfr/her2
|
|
US7439358B2
(en)
|
2006-02-08 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
|
|
WO2007102767A1
(en)
|
2006-03-07 |
2007-09-13 |
Astrazeneca Ab |
Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
|
|
EP2540725A1
(de)
|
2006-05-04 |
2013-01-02 |
Boehringer Ingelheim International GmbH |
Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
|
|
WO2009019205A1
(en)
|
2007-08-03 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Crystalline form of a dihydropteridione derivative
|
|
JP4642085B2
(ja)
|
2008-01-17 |
2011-03-02 |
日本下水道事業団 |
予測健全度を利用した施設管理および更新計画システム
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
US8025863B2
(en)
*
|
2008-06-20 |
2011-09-27 |
Exxonmobil Research And Engineering Company |
Synthesis and use of MSE-framework type molecular sieves
|
|
WO2010025073A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Takeda Pharmaceutical Company Limited |
Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors
|
|
JP5815411B2
(ja)
|
2008-12-30 |
2015-11-17 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピリミジンジアミンキナーゼ阻害剤
|
|
WO2011069962A1
(en)
|
2009-12-07 |
2011-06-16 |
Boehringer Ingelheim International Gmbh |
Bibw 2992 for use in the treatment of triple negative breast cancer
|
|
JP5841548B2
(ja)
|
2010-02-17 |
2016-01-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロプテリジノン、その製造方法及び使用
|
|
US8546566B2
(en)
|
2010-10-12 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Process for manufacturing dihydropteridinones and intermediates thereof
|
|
US9358233B2
(en)
|
2010-11-29 |
2016-06-07 |
Boehringer Ingelheim International Gmbh |
Method for treating acute myeloid leukemia
|
|
US20130131069A1
(en)
|
2011-05-13 |
2013-05-23 |
Boehringer Ingelheim International Gmbh |
Method for treatment of solid malignancies including advanced or metastatic solid malignancies
|
|
US9370535B2
(en)
|
2011-05-17 |
2016-06-21 |
Boehringer Ingelheim International Gmbh |
Method for treatment of advanced solid tumors
|